hold on there's just too much going on in Congress lmao...
Ends vaccine manufacturer liability shield, allows direct lawsuits.
Senators Paul (R-KY) and Lee (R-UT) introduced this.
Introduced in Senate, no House vote yet
This bill aims to allow individuals to sue vaccine manufacturers and administrators directly in court for vaccine-related injuries or death, rather than primarily going through a federal compensation program. It also specifically removes liability protections for COVID-19 vaccine makers. Introduced by Senators Paul and Lee, it has been referred to the Senate Health, Education, Labor, and Pensions Committee for review.
Introduced Feb 11, 2026
The bill was introduced in the Senate on February 11, 2026, by Senators Paul and Lee. It has since been referred to the Senate Committee on Health, Education, Labor, and Pensions. For the bill to become law, it must pass both the Senate and the House of Representatives and then be signed by the President.
If this bill passes, individuals alleging vaccine-related injuries would no longer be required to first seek compensation through the National Vaccine Injury Compensation Program (VICP) and could immediately pursue civil lawsuits against vaccine manufacturers or administrators. Additionally, manufacturers of COVID-19 vaccines would lose the liability shield they currently hold under the PREP Act, making them subject to standard legal actions for damages. The VICP would still exist but would operate as an alternative path for compensation, not a prerequisite for civil action.
Supporters Say
Supporters argue it would hold vaccine manufacturers more accountable and provide clearer legal recourse for those harmed by vaccines.
Critics Say
Critics might express concerns that ending liability protections could hinder vaccine development or increase costs.
Proponents of this bill likely believe that manufacturers should bear full responsibility for their products, similar to other industries, ensuring justice for those who experience adverse effects. Opponents, however, might argue that the existing liability protections are crucial for encouraging vaccine innovation and production, especially during public health crises, and that removing them could have negative public health consequences.